Home Newsfeeds Citigroup Maintains Buy on Autodesk, Lowers Price Target to $256

Citigroup Maintains Buy on Autodesk, Lowers Price Target to $256

Citigroup analyst Tyler Radke maintains Autodesk (NASDAQ:ADSK) with a Buy and lowers the price target from $277 to $256.

byBenzinga Newsdesk

November 18, 2022

1 minute read

Citigroup analyst Tyler Radke maintains Autodesk (NASDAQ:ADSK) with a Buy and lowers the price target from $277 to $256.

HC Wainwright & Co. Reiterates Buy on Syros Pharmaceuticals, Maintains $15 Price Target

By Benzinga Newsdesk

March 3, 7:10 AM

HC Wainwright & Co. analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and maintains $15 price target.

SYRS

HEXO Regains Compliance With Nasdaq Minimum Bid Price Requirement

By Vuk Zdinjak

January 20, 8:39 AM

HEXO Corp. (NASDAQ: HEXO) (TSX:HEXO) has received formal notice from The Nasdaq Stock Market LLC stating that the company has regained compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Stock Market.

HEXO

ThredUp Q4 EPS $(0.19) Beats $(0.20) Estimate, Sales $71.32M Beat $63.03M Estimate

By Michael Horton

March 6, 5:11 PM

ThredUp (NASDAQ:TDUP) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 5.56 percent decrease over losses of $(0.18) per share from the same

TDUP

Flora Growth’s Shares Soar On Securing A ‘Crucial Footprint In An Established International Cannabis Market’

By Vuk Zdinjak

December 27, 8:48 AM

Flora Growth Corp. (NASDAQ: FLGC) on December 23, 2022, it closed the acquisition of all of the issued and outstanding shares of Franchise Global Health Inc. (TSXV:FGH).

FLGC

Citigroup Maintains Buy on Autodesk, Lowers Price Target to $256

Related Posts

HC Wainwright & Co. Reiterates Buy on Syros Pharmaceuticals, Maintains $15 Price Target

HEXO Regains Compliance With Nasdaq Minimum Bid Price Requirement

ThredUp Q4 EPS $(0.19) Beats $(0.20) Estimate, Sales $71.32M Beat $63.03M Estimate

Flora Growth’s Shares Soar On Securing A ‘Crucial Footprint In An Established International Cannabis Market’